Yokoyama I, Murakami T, Ohtake T, Momomura S, Nishikawa J, Sasaki Y, Omata M
Second Department of Internal Medicine, University of Tokyo, Japan.
J Nucl Med. 1996 Dec;37(12):1937-42.
Familial hypercholesterolemia (FH) presents the highest risk for coronary artery disease (CAD) among patients with hyperlipidemia. Therefore, early detection of coronary arterial atherosclerosis is important for the treatment of FH patients. The aim of this study was to detect early coronary arterial abnormalities that may relate to future atherosclerosis in asymptomatic FH patients by measuring coronary flow reserve (CFR) using PET and 13N-ammonia.
Twenty-five patients with FH (14 men, 11 women) without a history of myocardial ischemia and 14 control subjects (9 men, 5 women) were studied. Total serum cholesterol (mmole/liter) was 5.33 +/- 0.66 in control subjects and 7.90 +/- 0.77 in FH patients (p < 0.01 versus control subjects).
Myocardial blood flow (MBF) at rest and during dipyridamole loading was measured using PET, and CFR was calculated. MBF (ml/min/100 g weight heart) at rest in the FH group (79.0 +/- 20.0) was comparable to that in control subjects (70.0 +/- 17.0). However, MBF during dipyridamole loading was significantly lower in FH patients (163.0 +/- 67.0) than in control subjects (286.0 +/- 120.0, p < 0.01). CFR in FH patients (2.09 +/- 0.62) was also significantly lower than that in control subjects (4.13 +/- 1.38, p < 0.01). CFR showed a gender-specific variance in FH patients (1.85 +/- 0.40 in men versus 2.55 +/- 0.74 in women p < 0.05) but not in control subjects. Significant inverse correlations between CFR and the total plasma cholesterol level as well as plasma LDL cholesterol were observed.
The CFR was reduced in patients with FH. This abnormality was more prominent in men than in women patients. Noninvasive assessment of CFR by 13N-ammonia PET was useful to detect early abnormalities of the coronary arteries in asymptomatic patients with FH.
家族性高胆固醇血症(FH)在高脂血症患者中呈现出患冠状动脉疾病(CAD)的最高风险。因此,早期检测冠状动脉粥样硬化对于FH患者的治疗很重要。本研究的目的是通过使用PET和13N-氨测量冠状动脉血流储备(CFR),来检测无症状FH患者中可能与未来动脉粥样硬化相关的早期冠状动脉异常。
研究了25例无心肌缺血病史的FH患者(14例男性,11例女性)和14例对照受试者(9例男性,5例女性)。对照受试者的总血清胆固醇(毫摩尔/升)为5.33±0.66,FH患者为7.90±0.77(与对照受试者相比,p<0.01)。
使用PET测量静息和双嘧达莫负荷时的心肌血流量(MBF),并计算CFR。FH组静息时的MBF(毫升/分钟/100克体重心脏)(79.0±20.0)与对照受试者(70.0±17.0)相当。然而,FH患者双嘧达莫负荷时的MBF(163.0±67.0)显著低于对照受试者(286.0±120.0,p<0.01)。FH患者的CFR(2.09±0.62)也显著低于对照受试者(4.13±1.38,p<0.01)。CFR在FH患者中显示出性别特异性差异(男性为1.85±0.40,女性为2.55±0.74,p<0.05),但在对照受试者中未显示。观察到CFR与总血浆胆固醇水平以及血浆低密度脂蛋白胆固醇之间存在显著的负相关。
FH患者的CFR降低。这种异常在男性患者中比女性患者更明显。通过13N-氨PET对CFR进行无创评估有助于检测无症状FH患者冠状动脉的早期异常。